TABLE 3.
Vaccine |
FDA (US) |
EMA (EU) |
MHRA (UK) |
DCGI (India) |
China | Russia | WHO |
---|---|---|---|---|---|---|---|
Pfizer/BioNTech | 11 December 2020 | 21 December 2020 | 2 December 2020 | NA | NA | NA | 31 December 2020 |
Moderna | 18 December 2020 | 6 January 2021 | 8 January 2021 | 29 June 2021 | NA | NA | 30 April 2021 |
Johnson & Johnson a | 27 February 2021 | 11 March 2021 | 28 May 2021 | NA | NA | NA | 12 March 2021 |
AstraZeneca | NA | 29 January 2021 | 30 December 2020 | 3 January 2021 | NA | NA | 15 February 2021 b |
Sinopharm | NA | NA | NA | NA | 5 February 2021 | NA | 7 May 2021 |
Sinovac | NA | NA | NA | NA | 31 August 2020 | NA | 1 June 2021 |
Sputnik V | NA | NA | NA | 20 April 2021 | NA | 2 December 2020 | NA |
Bharat Biotech | NA | NA | NA | 3 January 2021 | NA | NA | NA |
Novavax | NA | NA | NA | NA | NA | NA | NA |
CureVac | NA | NA | NA | NA | NA | NA | NA |
Dates are as of 15 July 2021.
Abbreviations: DCGI, Drugs Controller General of India; EMA, European Medicines Agency; FDA, Food and Drug Administration; MHRA, Medicines and Healthcare products Regulatory Agency; NA, Not authorised; WHO, World Health Organization.
Johnson & Johnson's vaccine was one dose, the others were all a two‐dose regimen.
The WHO ultimately issued an emergency use licence for the AstraZeneca vaccine from three sources: Serum Institute of India, SK bioscience and facilities in Europe.
Source: Constructed by the authors.